Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The lysosomal lumen is the acidic internal environment of the lysosome, a membrane-bound organelle essential for the degradation and recycling of macromolecules such as proteins, lipids, and polysaccharides. This compartment maintains a low pH (approximately 4.5–5.0) to optimize the activity of over 60 different acid hydrolases, which are critical for cellular waste management and homeostasis [1, 4]. Beyond degradation, the lysosomal lumen and its membrane serve as a signaling hub for nutrient sensing, particularly through the recruitment and activation of the mTORC1 complex [1]. Dysfunction in lysosomal processes is a hallmark of lysosomal storage diseases (LSDs), where the accumulation of undigested substrates leads to severe multi-systemic pathologies [2]. Furthermore, impaired lysosomal function is increasingly linked to neurodegenerative conditions like Parkinson's and Alzheimer's diseases, as well as cancer progression and drug resistance [2, 3]. Therapeutic strategies targeting the lysosomal lumen include lysosomotropic agents that alter pH, enzyme replacement therapies (ERT) to restore missing hydrolases, and small molecules designed to enhance lysosomal biogenesis or stability [3].
Modulation of lysosomal pH, inhibition of vacuolar-type H+-ATPase (V-ATPase), enzyme replacement therapy (ERT), or substrate reduction therapy (SRT).
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Lysosomal lumen.